High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.

OBJECTIVES: To assess the safety and feasibility of high-intensity focused ultrasound (HIFU) ablation of liver tumours and to determine whether post-operative MRI correlates with intra-operative imaging. METHODS: 31 patients were recruited into two ethically approved clinical trials (median age 64;...

Full description

Bibliographic Details
Main Authors: Leslie, T, Ritchie, R, Illing, R, Ter Haar, G, Phillips, R, Middleton, M, Bch, B, Wu, F, Cranston, D
Format: Journal article
Language:English
Published: 2012
_version_ 1826270628081041408
author Leslie, T
Ritchie, R
Illing, R
Ter Haar, G
Phillips, R
Middleton, M
Bch, B
Wu, F
Cranston, D
author_facet Leslie, T
Ritchie, R
Illing, R
Ter Haar, G
Phillips, R
Middleton, M
Bch, B
Wu, F
Cranston, D
author_sort Leslie, T
collection OXFORD
description OBJECTIVES: To assess the safety and feasibility of high-intensity focused ultrasound (HIFU) ablation of liver tumours and to determine whether post-operative MRI correlates with intra-operative imaging. METHODS: 31 patients were recruited into two ethically approved clinical trials (median age 64; mean BMI 26 kg m(-2)). Patients with liver tumours (primary or metastatic) underwent a single HIFU treatment monitored using intra-operative B-mode ultrasound. Follow-up consisted of radiology and histology (surgical trial) or radiology alone (radiology trial). Radiological follow-up was digital subtraction contrast-enhanced MRI. RESULTS: Treatment according to protocol was possible in 30 of 31 patients. One treatment was abandoned because of equipment failure. Transient pain and superficial skin burns were seen in 81% (25/31) and 39% (12/31) of patients, respectively. One moderate skin burn occurred. One patient died prior to radiological follow-up. Radiological evidence of ablation was seen in 93% (27/29) of patients. Ablation accuracy was good in 89% (24/27) of patients. In three patients the zone of ablation lay ≤2 mm outside the tumour. The median cross-sectional area (CSA) of the zone of ablation was 5.0 and 5.1 cm(2) using intra-operative and post-operative imaging, respectively. The mean MRI:B-mode CSA ratio was 1.57 [95% confidence interval (CI)=0.57-2.71]. There was positive correlation between MRI and B-mode CSA (Spearman's r=0.48; 95% CI 0.11-0.73; p=0.011) and the slope of linear regression was significantly non-zero (1.23; 95% CI=0.68-1.77; p<0.0001). CONCLUSIONS: HIFU ablation of liver tumours is safe and feasible. HIFU treatment is accurate, and intra-operative assessment of treatment provides an accurate measure of the zone of ablation and correlates well with MRI follow-up.
first_indexed 2024-03-06T21:43:50Z
format Journal article
id oxford-uuid:48dad82c-065b-419d-847a-1aabffe98988
institution University of Oxford
language English
last_indexed 2024-03-06T21:43:50Z
publishDate 2012
record_format dspace
spelling oxford-uuid:48dad82c-065b-419d-847a-1aabffe989882022-03-26T15:28:11ZHigh-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:48dad82c-065b-419d-847a-1aabffe98988EnglishSymplectic Elements at Oxford2012Leslie, TRitchie, RIlling, RTer Haar, GPhillips, RMiddleton, MBch, BWu, FCranston, D OBJECTIVES: To assess the safety and feasibility of high-intensity focused ultrasound (HIFU) ablation of liver tumours and to determine whether post-operative MRI correlates with intra-operative imaging. METHODS: 31 patients were recruited into two ethically approved clinical trials (median age 64; mean BMI 26 kg m(-2)). Patients with liver tumours (primary or metastatic) underwent a single HIFU treatment monitored using intra-operative B-mode ultrasound. Follow-up consisted of radiology and histology (surgical trial) or radiology alone (radiology trial). Radiological follow-up was digital subtraction contrast-enhanced MRI. RESULTS: Treatment according to protocol was possible in 30 of 31 patients. One treatment was abandoned because of equipment failure. Transient pain and superficial skin burns were seen in 81% (25/31) and 39% (12/31) of patients, respectively. One moderate skin burn occurred. One patient died prior to radiological follow-up. Radiological evidence of ablation was seen in 93% (27/29) of patients. Ablation accuracy was good in 89% (24/27) of patients. In three patients the zone of ablation lay ≤2 mm outside the tumour. The median cross-sectional area (CSA) of the zone of ablation was 5.0 and 5.1 cm(2) using intra-operative and post-operative imaging, respectively. The mean MRI:B-mode CSA ratio was 1.57 [95% confidence interval (CI)=0.57-2.71]. There was positive correlation between MRI and B-mode CSA (Spearman's r=0.48; 95% CI 0.11-0.73; p=0.011) and the slope of linear regression was significantly non-zero (1.23; 95% CI=0.68-1.77; p<0.0001). CONCLUSIONS: HIFU ablation of liver tumours is safe and feasible. HIFU treatment is accurate, and intra-operative assessment of treatment provides an accurate measure of the zone of ablation and correlates well with MRI follow-up.
spellingShingle Leslie, T
Ritchie, R
Illing, R
Ter Haar, G
Phillips, R
Middleton, M
Bch, B
Wu, F
Cranston, D
High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.
title High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.
title_full High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.
title_fullStr High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.
title_full_unstemmed High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.
title_short High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume.
title_sort high intensity focused ultrasound treatment of liver tumours post treatment mri correlates well with intra operative estimates of treatment volume
work_keys_str_mv AT lesliet highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume
AT ritchier highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume
AT illingr highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume
AT terhaarg highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume
AT phillipsr highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume
AT middletonm highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume
AT bchb highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume
AT wuf highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume
AT cranstond highintensityfocusedultrasoundtreatmentoflivertumoursposttreatmentmricorrelateswellwithintraoperativeestimatesoftreatmentvolume